In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity
about
Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.Cytokine-induced NK-like T cells: from bench to bedside.NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects.IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor.Arming cytokine-induced killer cells with chimeric antigen receptors: CD28 outperforms combined CD28-OX40 "super-stimulation".Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease.CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHDHDAC inhibition and graft versus host diseaseCisplatin pretreatment enhances anti-tumor activity of cytokine-induced killer cells.Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantationImmunotherapy for hepatocellular carcinoma: From basic research to clinical use.Treatment of CD33-directed chimeric antigen receptor-modified T cells in one patient with relapsed and refractory acute myeloid leukemia.NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCTIFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.The therapeutic effect of cytokine-induced killer cells on pancreatic cancer enhanced by dendritic cells pulsed with K-ras mutant peptideDonor colonic CD103+ dendritic cells determine the severity of acute graft-versus-host disease.Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells.Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.Cytokine-induced killer (CIK) cells: from basic research to clinical translation.Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model.Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion.Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effectsAdjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.Immune-based Therapy Clinical Trials in Hepatocellular CarcinomaCytokine-induced killer cell therapy for the treatment of primary hepatocellular carcinoma subsequent to liver transplantation: A case reportImplication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer.Targeting deacetylases to improve outcomes after allogeneic bone marrow transplantation.IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapyBiological Character of RetroNectin Activated Cytokine-Induced Killer Cells.NaHCO3 enhances the antitumor activities of cytokine-induced killer cells against hepatocellular carcinoma HepG2 cellsCytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation.Early efficacy of stereotactic body radiation therapy combined with adoptive immunotherapy for advanced malignanciesImmunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform.In vivo proof of concept of adoptive immunotherapy for hepatocellular carcinoma using allogeneic suicide gene-modified killer cells.New perspectives on the biology of acute GVHD.Manipulating the expression of chemokine receptors enhances delivery and activity of cytokine-induced killer cells.Host bone marrow-derived IL-12 enhances donor T cell engraftment in a mouse model of bone marrow transplantation.Immunoregulation of GVHD by triggering the innate immune system with CpG.Mouse models of graft-versus-host disease: advances and limitations
P2860
Q33429758-7E91C970-5F4E-4DA9-A8FE-66C0514D06D0Q33762499-D75EE46E-47AA-49EB-8376-5A49294A35CEQ33887452-BE7F4B92-6A97-456A-B130-6F28E9E954B7Q34077847-B0EEE7C8-D6A2-40E5-A0D7-5123E8A7A1C1Q34329186-0BA1DC49-D3E7-476C-A1DA-065FDA9818E9Q34367252-732AC469-3C59-4317-9870-72D9AD777113Q34568892-351B5944-C086-4A6C-AB44-93204E21BA48Q34707286-85F2139A-4290-4642-8B90-2E9F1C4E2B41Q35016985-C6E4D4ED-C7E9-4979-9A38-1A2B8C673F41Q35093618-28F679D8-63E1-472D-97ED-C3077B08D015Q35218943-55B39938-34EF-439C-80CA-493248AF3DB1Q35567765-A17712FA-5E6C-4A15-8719-676D42D46B32Q35591409-D4816F3D-9415-4C71-B510-BB6D0CC1D7EAQ35692428-206CA505-B0E6-4DC7-9813-131AB2C2AD60Q35733767-FA95A491-364F-47C0-83B1-D140FF8A292FQ35755295-54014CED-6471-49B8-AF67-9F5CBD423232Q35894369-DDD25E73-C06E-454F-BF2E-BA6BE0ED6AAEQ36057599-D8850194-A8A5-4F5B-8B97-84A7F1718F2EQ36106330-7ED6117C-0712-4179-8DD6-9D0A02500D9AQ36121153-AF2A1008-B336-46AC-AD94-FFCE78602CE0Q36137504-DE6B5AFF-735B-49A9-913A-8D29C94D8BDBQ36351988-4C14D8DA-81AB-4DE8-A497-0DB41D7A0C88Q36380188-F3C9C72A-E933-4F45-98A1-9F3166B00CD8Q36566943-40ED9105-1347-4E9A-863F-733D563E85C2Q36571270-76E7AF81-B13C-4283-A8EB-51A60231ED21Q36640769-50680B3C-CF54-4011-A1A9-5E3C396B8B5EQ36962962-7DFAF45F-7154-4BE5-949E-9EDDEEC9A1D6Q37026059-6F76F1E1-0A58-4420-B415-67CC6A302F6BQ37041732-02D92E60-4E31-44FD-A777-2BE3BB089461Q37084335-B940B155-BDA9-4CD1-90A7-DD02FCFA715FQ37406855-5E14982B-8A58-43BD-968F-101E825C5AAEQ37492611-14E4824F-ADCE-4341-A212-62EB9B18DB50Q37560863-61CCC107-E2C5-4AC4-9E9C-05A4EFB539E9Q37588329-41B489F6-5672-4DC7-801B-A96EE7AFDA26Q37620831-B6373283-1817-4585-99D3-E25AE3D75437Q37641063-4D6D06E5-0A8F-4EBE-B7F7-AF06FC6499FBQ37711663-F306A4CD-D1FF-4AE9-AF67-04BF712AB19BQ37717313-F85EAA82-6DD1-4EFC-9D72-53A0E8EAA2F7Q37810081-B86E3BD0-4D16-42F3-9282-8CE0B70ECC93Q37874011-64DEC93F-66B9-47DB-B7B9-35D50C584DC5
P2860
In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
In vivo trafficking and surviv ...... etention of antitumor activity
@en
type
label
In vivo trafficking and surviv ...... etention of antitumor activity
@en
prefLabel
In vivo trafficking and surviv ...... etention of antitumor activity
@en
P2093
P2860
P1433
P1476
In vivo trafficking and surviv ...... etention of antitumor activity
@en
P2093
Andreas Beilhack
Emanuela I Sega
Janelle A Olson
Jeanette Baker
Mobin Karimi
Robert S Negrin
Robert Zeiser
Ryosei Nishimura
P2860
P304
P356
10.1182/BLOOD-2007-06-092817
P407
P577
2008-06-18T00:00:00Z